WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule

About this update from Well Health Technologies Corp.

WELL has reached its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada, three calendar quarters ahead of schedule, driven by strong organic growth across WELL Clinics and WELLSTAR together with two accretive acquisitions.WELL had previously guided a $100 million annualized Adjusted EBITDA(1) run-rate by Q1-2027 on approximately $800 million of revenue. The Company has delivered it on approximately $700 million of revenue, implying an Adjusted EBITDA Margin(1) of approximately 14% - roughly 180 basis points ahead of prior guidance.On June 1, 2026, WELL closed two complementary, immediately accretive acquisitions in Ontario and Québec, focused on diagnostic imaging and procedural care: 100% of the OID Group and approximately 65% controlling interest in UnionMD. The Company paid approximately $115 million at closing for both acquisitions, expanding its Canadian Clinics network to approximately 270 clinics nationally. The total purchase price for these two transactions could amount to $160 million, inclusive of future earn-outs and vendor take-back financing.The two acquisitions generated combined Adjusted EBITDA(1) of approximately $22 million in 2025, reflecting Adjusted EBITDA Margins(1) of well over 25%, and bringing WELL Canadian Clinics to well over $80 million in annualized Adjusted EBITDA(1) run-rate.On the strength of this performance and the contribution of the completed acquisitions, WELL now expects to exceed the top end of its previously announced 2026 Adjusted EBITDA(1) guidance range of $175 million to $185 million. The Company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.Vancouver, British Columbia--(Newsfile Corp. - June 2, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, today announced that it has achieved its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for its WELL Canada segment, three calendar quarters ahead of the timeline it had previously guided to, and at materially better margins. This milestone reflects the combined strength of WELL's organic growth and its disciplined acquisition strategy across the C...

View stock analysis, news, and events for Well Health Technologies Corp.